Page 1 | Search Results | Blood | American Society of Hematology

1-14 of 14

Sort by

Sort Order Select

Journal Articles

Integrative single-cell chromatin and transcriptome analysis of human plasma cell differentiation

Elina Alaterre, Sara Ovejero, Caroline Bret, Laure Dutrieux, Dassou Sika, Raul Fernandez Perez, Marion Espéli, Thierry Fest, Michel Cogné, José Ignacio Martin-Subero, Pierre Milpied, Giacomo Cavalli, Jérôme Moreaux

Blood (2024) 144 (5): 496–509.

https://doi.org/10.1182/blood.2023023237

Published: 2024

Includes: Supplemental data

Journal Articles

Combination Chemotherapy in Patients with Newly Diagnosed Blastic Plasmacytoid Dendritic Cell Neoplasms (BPDCN): First Results of a Prospective French Trial (LpDessai)

Blood (2023) 142 (Supplement 1): 1516.

https://doi.org/10.1182/blood-2023-173379

Published: 2023

Journal Articles

Epigenetic Modifiers MMSET and EZH2 Physically Interact and Cooperate to Support Multiple Myeloma Pathophysiology

Emmanuel Varlet, Elina Alaterre, Morgane Thomas, Hugues De Boussac, Laure Vincent, Guillaume Cartron, Charles Herbaux, Caroline Bret, Laurie Herviou, Anne Marie Martinez, Christophe Hirtz, Aurore Attina, Jerome Vialaret, Giacomo Cavalli, Jerome Moreaux, Sara Ovejero

Blood (2023) 142 (Supplement 1): 1964.

https://doi.org/10.1182/blood-2023-181018

Published: 2023

Journal Articles

Early Progressions of Undetermined Significance (EPUS) in the Month Following CAR-T Cells for B-Cell NHL Is Mainly Related to Pseudoprogression

Benoît Tisserand, Caroline Bret, Yassine Al Tabaa, Sylvain Lamure, Xavier Ayrignac, Laura Platon, Patrice Ceballos, Ludovic Gabellier, Jerome Moreaux, Charles Herbaux, Guillaume Cartron, Jean-Jacques Tudesq

Blood (2023) 142 (Supplement 1): 3124.

https://doi.org/10.1182/blood-2023-185520

Published: 2023

Journal Articles

Targeting Iron Homeostasis As a Therapeutic Strategy in Multiple Myeloma

Sara ovejero-Merino, Julie Devin, Tatiana Cañeque, Laura Alibert, Guilhem Requirand, Nicolas Robert, Alizée Steer, Amelie Machura, Christophe Hirtz, Angélique Bruyer, Laure Vincent, Guillaume Cartron, Charles Herbaux, Raphael Rodriguez, Caroline Bret, Jerome Moreaux

Blood (2022) 140 (Supplement 1): 9980–9981.

https://doi.org/10.1182/blood-2022-163252

Published: 2022

Journal Articles

Ironomycin Induces Mantle Cell Lymphoma Cell Death By Targeting Iron Metabolism Addiction

Sara ovejero-Merino, Laura Alibert, Julie Devin, Tatiana Cañeque, Ouissem Karmous Gadacha, Matthieu Abouladze, Guilhem Requirand, Nicolas Robert, Hugues De Boussac, Guillaume Cartron, Charles Herbaux, Raphael Rodriguez, Jerome Moreaux, Caroline Bret

Blood (2022) 140 (Supplement 1): 6439–6440.

https://doi.org/10.1182/blood-2022-164644

Published: 2022

Journal Articles

Kte-X19 in Relapsed or Refractory Mantle-Cell Lymphoma, a "Real-Life" Study from the Descar-T Registry and Lysa Group

Blood (2021) 138 (Supplement 1): 743.

https://doi.org/10.1182/blood-2021-148626

Published: 2021

Journal Articles

Targeting DNA Repair to Overcome Drug Resistance in Hodgkin Lymphoma

Julie Devin, PharmD, Quentin Denis, Caroline Bret, PhD PharmD, Jerome Moreaux, PhD

Blood (2020) 136 (Supplement 1): 26.

https://doi.org/10.1182/blood-2020-142510

Published: 2020

Journal Articles

DNA Repair Expression Profiling to Identify High-Risk Cytogenetically Normal Acute Myeloid Leukemia and Define New Therapeutic Targets

Ludovic Gabellier, MD, Caroline Bret, PhD PharmD, Guillaume Bossis, PhD, Guillaume Cartron, MD PhD, Jerome Moreaux, PhD

Blood (2020) 136 (Supplement 1): 35.

https://doi.org/10.1182/blood-2020-137417

Published: 2020

Journal Articles

Ironomycin Induces Diffuse Large B-Cell Lymphoma Cell Death By Targeting Iron Metabolism Addiction

Julie Devin, PharmD, Tatiana Cañeque, Yea-Lih Lin, PhD, Guillaume Cartron, Philippe Pasero, PhD, Caroline Bret, PhD PharmD, Raphael Rodriguez, Jerome Moreaux, PhD

Blood (2019) 134 (Supplement_1): 3960.

https://doi.org/10.1182/blood-2019-129954

Published: 2019

Journal Articles

Targeting DNA Repair Mechanisms to Overcome Drug Resistance in Diffuse Large B Cell Lymphoma

Julie Devin, Yea-Lih Lin, PhD, Alboukadel Kassambara, PhD, Guillaume Cartron, Olivier Elemento, PhD, Angelos Constantinou, PhD, Philippe Pasero, PhD, Caroline Bret, PhD PharmD, Jerome Moreaux, PhD

Blood (2017) 130 (Supplement 1): 1479.

https://doi.org/10.1182/blood.V130.Suppl_1.1479.1479

Published: 2017

Journal Articles

Malignant Plasma Cells Responsible for Multiple Myeloma Relapse Are Detectable and Survive Nine Days After High Dose Melphalan: Highlight of An Optimal Therapeutic Window ?

Anouk Caraux, PhD, Laure Vincent, Jerome Moreaux, PhD, Guilhem Requirand, Caroline Bret, PharmD, PhD, Jean-Luc Veyrune, PhD, Christophe Duperray, Salahedine Bouhya, MD, Jean-Francois Rossi, MD, PhD, Bernard Klein, PhD

Blood (2011) 118 (21): 131.

https://doi.org/10.1182/blood.V118.21.131.131

Published: 2011

Journal Articles

An in vitro model of differentiation of memory B cells into plasmablasts and plasma cells including detailed phenotypic and molecular characterization

Michel Jourdan, Anouk Caraux, John De Vos, Geneviève Fiol, Marion Larroque, Chantal Cognot, Caroline Bret, Christophe Duperray, Dirk Hose, Bernard Klein

Blood (2009) 114 (25): 5173–5181.

https://doi.org/10.1182/blood-2009-07-235960

Published: 2009

Includes: Supplemental data

Journal Articles

An in Vitro Model of Differentiation of Memory B Cells Into Plasmablasts and Plasma Cells Including Detailed Phenotypic and Molecular Characterization.

Michel Jourdan, Anouk Caraux, John De Vos, PhD, Geneviève Fiol, Marion Larroque, Chantal Cognot, Caroline Bret, Christophe Duperray, Dirk Hose, Bernard Klein

Blood (2009) 114 (22): 1636.

https://doi.org/10.1182/blood.V114.22.1636.1636

Published: 2009

NARROW

Integrative single-cell chromatin and transcriptome analysis of human plasma cell differentiation

Combination Chemotherapy in Patients with Newly Diagnosed Blastic Plasmacytoid Dendritic Cell Neoplasms (BPDCN): First Results of a Prospective French Trial (LpDessai)

Epigenetic Modifiers MMSET and EZH2 Physically Interact and Cooperate to Support Multiple Myeloma Pathophysiology

Early Progressions of Undetermined Significance (EPUS) in the Month Following CAR-T Cells for B-Cell NHL Is Mainly Related to Pseudoprogression

Targeting Iron Homeostasis As a Therapeutic Strategy in Multiple Myeloma

Ironomycin Induces Mantle Cell Lymphoma Cell Death By Targeting Iron Metabolism Addiction

Kte-X19 in Relapsed or Refractory Mantle-Cell Lymphoma, a "Real-Life" Study from the Descar-T Registry and Lysa Group

Targeting DNA Repair to Overcome Drug Resistance in Hodgkin Lymphoma

DNA Repair Expression Profiling to Identify High-Risk Cytogenetically Normal Acute Myeloid Leukemia and Define New Therapeutic Targets

Ironomycin Induces Diffuse Large B-Cell Lymphoma Cell Death By Targeting Iron Metabolism Addiction

Targeting DNA Repair Mechanisms to Overcome Drug Resistance in Diffuse Large B Cell Lymphoma

Malignant Plasma Cells Responsible for Multiple Myeloma Relapse Are Detectable and Survive Nine Days After High Dose Melphalan: Highlight of An Optimal Therapeutic Window ?

An in vitro model of differentiation of memory B cells into plasmablasts and plasma cells including detailed phenotypic and molecular characterization

An in Vitro Model of Differentiation of Memory B Cells Into Plasmablasts and Plasma Cells Including Detailed Phenotypic and Molecular Characterization.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only